Showing results (61-70 of 91) with videos related to
Sort By:
Pageof 10
Blood Cancer Journal|October 16, 2025
Advanced stage classical Hodgkin lymphoma patients with a positive interim-PET (PET-2) Deauville score 5 after 2 ABVD cycles: a pooled analysis of three multicenter trialsSimonetta Viviani, Chiara Pavoni, Sally F Barrington, et al.Ejhaem|February 10, 2025
Immune Signatures Identify Patient Subsets Deriving Long-Term Benefit From First-Line Rituximab in Follicular LymphomaGinevra Lolli, Alessandro Davini, Valentina Tabanelli, et al.Blood|February 28, 2004
Telomere length correlates with histopathogenesis according to the germinal center in mature B-cell lymphoproliferative disordersMarco Ladetto, Mara Compagno, Irene Ricca, et al.British Journal of Haematology|May 11, 2012
Phase II study of sorafenib in patients with relapsed or refractory lymphomaAnna Guidetti, Carmelo Carlo-Stella, Silvia L Locatelli, et al.Annals of Hematology|June 6, 2013
Rituximab-based pre-emptive treatment of molecular relapse in follicular and mantle cell lymphomaSimone Ferrero, Luigia Monitillo, Barbara Mantoan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2003
PCR-detectable nonneoplastic Bcl-2/IgH rearrangements are common in normal subjects and cancer patients at diagnosis but rare in subjects treated with chemotherapyMarco Ladetto, Daniela Drandi, Mara Compagno, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2015
High Doses of Antimetabolites Followed by High-Dose Sequential Chemoimmunotherapy and Autologous Stem-Cell Transplantation in Patients With Systemic B-Cell Lymphoma and Secondary CNS Involvement: Final Results of a Multicenter Phase II TrialAndrés J M Ferreri, Giovanni Donadoni, Maria Giuseppina Cabras, et al.Blood Advances|February 22, 2023
Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCLSaveria Mazzara, Laura Travaini, Francesca Botta, et al.Muscle & Nerve|January 22, 2011
Repeated courses of granulocyte colony-stimulating factor in amyotrophic lateral sclerosis: clinical and biological results from a prospective multicenter studyAdriano Chiò, Gabriele Mora, Vincenzo La Bella, et al.Hematological Oncology|July 1, 2020
Early serum TARC reduction predicts prognosis in advanced-stage Hodgkin lymphoma patients treated with a PET-adapted strategySimonetta Viviani, Arabella Mazzocchi, Chiara Pavoni, et al.Pageof 10